Cary.

PositionTriangle

CARY--Cornerstone Therapeutics will acquire Bedminster, N.J.-based pharmaceutical company EKR Therapeutics for $150 million. Cornerstone, which specializes in commercializing products for hospitals, will gain access to two drugs--a short-term...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT